miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer

por Hidekazu Hiramoto, Tomoki Muramatsu, Daisuke Ichikawa, Kousuke Tanimoto, Satoru Yasukawa, Eigo Otsuji, Johji Inazawa
Publicado 2017

β-Galactosidase is a target enzyme for detecting peritoneal metastasis of gastric cancer

por Hidemasa Kubo, Yasutoshi Murayama, Soichiro Ogawa, Tatsuya Matsumoto, Masayuki Yubakami, Takuma Ohashi, Takeshi Kubota, Kazuma Okamoto, Mako Kamiya, Yasuteru Urano, Eigo Otsuji
Publicado 2021

Rapid fluorescence imaging of human hepatocellular carcinoma using the β-galactosidase-activatable fluorescence probe SPiDER-βGal

por Soichiro Ogawa, Hidemasa Kubo, Yasutoshi Murayama, Takeshi Kubota, Masayuki Yubakami, Tatsuya Matsumoto, Yusuke Yamamoto, Ryo Morimura, Hisashi Ikoma, Kazuma Okamoto, Mako Kamiya, Yasuteru Urano, Eigo Otsuji
Publicado 2021

Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer

por Taisuke Imamura, Shuhei Komatsu, Daisuke Ichikawa, Mahito Miyamae, Wataru Okajima, Takuma Ohashi, Jun Kiuchi, Keiji Nishibeppu, Hirotaka Konishi, Atsushi Shiozaki, Ryo Morimura, Hisashi Ikoma, Toshiya Ochiai, Kazuma Okamoto, Hiroki Taniguchi, Eigo Otsuji
Publicado 2017